Voyager Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Voyager Therapeutics, Inc.‘s stocks are currently a part of 44 hedge funds’ portfolios, which represents 19.17% of the total amount of its stocks outstanding. This makes up a total of 7.35M shares of Voyager Therapeutics, Inc.. Compared to the previous quarter, the number fell by -67.83% or -15.50M shares fewer. As for the holding position changes, 27.27% (12) of current hedge fund investors increased the number of shares held, 15.91% (7) of current holders sold a part of the shares held, and 13.64% (6) closed the holdings completely. 15 hedge funds are new holders of Voyager Therapeutics, Inc. stock in Q1 2023, it is 34.09% of total holders.
Hedge funds holding Voyager Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 125 |
|---|---|
| Q3 2018 | 118 |
| Q4 2018 | 113 |
| Q1 2019 | 109 |
| Q2 2019 | 122 |
| Q3 2019 | 129 |
| Q4 2019 | 136 |
| Q1 2020 | 115 |
| Q2 2020 | 109 |
| Q3 2020 | 105 |
| Q4 2020 | 95 |
| Q1 2021 | 95 |
| Q2 2021 | 72 |
| Q3 2021 | 63 |
| Q4 2021 | 53 |
| Q1 2022 | 66 |
| Q2 2022 | 74 |
| Q3 2022 | 67 |
| Q4 2022 | 69 |
| Q1 2023 | 44 |
Hedge funds changes in Voyager Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 29 | 48 | 29 | 11 | 8 |
|---|---|---|---|---|---|
| Q3 2018 | 17 | 41 | 35 | 24 | 1 |
| Q4 2018 | 19 | 34 | 36 | 23 | 1 |
| Q1 2019 | 18 | 41 | 32 | 22 | -4 |
| Q2 2019 | 33 | 47 | 27 | 16 | -1 |
| Q3 2019 | 27 | 51 | 27 | 21 | 3 |
| Q4 2019 | 26 | 46 | 40 | 18 | 6 |
| Q1 2020 | 9 | 47 | 37 | 29 | -7 |
| Q2 2020 | 14 | 34 | 39 | 20 | 2 |
| Q3 2020 | 14 | 24 | 40 | 18 | 9 |
| Q4 2020 | 9 | 31 | 34 | 18 | 3 |
| Q1 2021 | 19 | 30 | 30 | 17 | -1 |
| Q2 2021 | 15 | 18 | 28 | 38 | -27 |
| Q3 2021 | 8 | 15 | 31 | 17 | -8 |
| Q4 2021 | 11 | 11 | 22 | 23 | -14 |
| Q1 2022 | 19 | 18 | 17 | 6 | 6 |
| Q2 2022 | 23 | 16 | 24 | 15 | -4 |
| Q3 2022 | 6 | 23 | 19 | 15 | 4 |
| Q4 2022 | 15 | 17 | 18 | 13 | 6 |
| Q1 2023 | 15 | 12 | 7 | 6 | 4 |
Hedge funds changes in Voyager Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 1,080,000 | 683,000 |
|---|---|---|
| Q3 2018 | 655,000 | 533,000 |
| Q4 2018 | 248,000 | 0 |
| Q1 2019 | 1,537,000 | 309,000 |
| Q2 2019 | 7,259,000 | 890,000 |
| Q3 2019 | 1,674,000 | 18,000 |
| Q4 2019 | 830,000 | 13,000 |
| Q1 2020 | 194,000 | 9,000 |
| Q2 2020 | 1,450,000 | 12,000 |
| Q3 2020 | 346,000 | 0 |
| Q4 2020 | 190,000 | 1,681,000 |
| Q1 2021 | 300,000 | 1,622,000 |
| Q2 2021 | 718,000 | 747,000 |
| Q3 2021 | 272,000 | 116,000 |
| Q4 2021 | 899,000 | 369,000 |
| Q1 2022 | 4,284,000 | 1,064,000 |
| Q2 2022 | 4,432,000 | 619,000 |
| Q3 2022 | 4,474,000 | 440,000 |
| Q4 2022 | 833,570 | 33,320 |
| Q1 2023 | 913,092,000 | 1,159,069,000 |